(Q37704062)

22 August 2017

1 reference

title

Update in tuberculosis 2009. (English)

1 reference

22 August 2017

0 references

Charles L Daley

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

22 August 2017

published in

1 reference

22 August 2017

volume

181

1 reference

22 August 2017

issue

6

1 reference

22 August 2017

page(s)

550-555

1 reference

Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Overseas screening for tuberculosis in U.S.-bound immigrants and refugees

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Assessing the performance of overseas tuberculosis screening programs: a study among US-bound immigrants in Vietnam

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Increasing proportions of advanced pulmonary tuberculosis reported in the United States: are delays in diagnosis on the rise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Yield of acid-fast smear and mycobacterial culture for tuberculosis diagnosis in people with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

HIV infection does not affect active case finding of tuberculosis in South African gold miners

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Bronchoalveolar lavage enzyme-linked immunospot for a rapid diagnosis of tuberculosis: a Tuberculosis Network European Trialsgroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

The diarylquinoline TMC207 for multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

A once-weekly R207910-containing regimen exceeds activity of the standard daily regimen in murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Daily dosing of rifapentine cures tuberculosis in three months or less in the murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201001-0140UP

10.1164/RCCM.201001-0140UP

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference